Last reviewed · How we verify
Inosital (INOSITOL)
Inosital works by influencing the metabolism of lipids in the body.
Inosital (INOSITOL) is a small molecule drug in the inositol class, originally developed by an unknown entity. It is currently owned by an unknown entity and has been approved for various indications including hypercholesterolemia, hypertriglyceridemia, and myocardial reinfarction prevention. The commercial status of Inosital is unknown, and it is not clear if it is patented or available as a generic. Key safety considerations are not well-documented. Inosital is used to treat conditions related to lipid metabolism.
At a glance
| Generic name | INOSITOL |
|---|---|
| Drug class | inositol |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | discontinued |
Mechanism of action
Think of Inosital like a key that helps unlock the body's natural ability to regulate cholesterol and triglyceride levels. When we eat, our body breaks down fats into smaller particles called lipids, which can be either good or bad for our health. Inosital helps the body use these lipids more efficiently, reducing the risk of conditions like high cholesterol and heart disease.
Approved indications
- Hypercholesterolemia
- Hypertriglyceridemia
- Hypoalphalipoproteinemia
- Mixed hyperlipidemia
- Myocardial Reinfarction Prevention
- Niacin deficiency
- Pellagra
- Slow Progression of Coronary Artery Disease
Common side effects
- Allergic sensitization
- Nausea
Key clinical trials
- Myo-Inositol for Infertility in PCOS (NA)
- Berberine Phytosome for Signs and Symptoms of Polycystic Ovary Syndrome (PCOS) (NA)
- A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth (PHASE4)
- Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome. (NA)
- Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study (PHASE1)
- Comparative Effect of Myo-inositol With That of D-chiro-inositol on Insulin Resistance in Infertile Women With Polycystic Ovary Syndrome (PCOS). (NA)
- Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel (NA)
- Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |